Long-Acting Cabotegravir and Rilpivirine: Innovation, New Challenges, and Opportunities. Llibre JM, Kuritzkes DAR. Clin Infect Dis 2023;76:1655-1657.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Llibre JM, Kuritzkes DAR. Long-Acting Cabotegravir and Rilpivirine: Innovation, New Challenges, and Opportunities. Clin Infect Dis 2023;76:1655-1657.
PMID: 36660823